All In MedTech

FDA Clearance Tracker · P120008-S014

Alinity i AFP

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 23, 2020 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P120008-S014
Device name
Alinity i AFP
Applicant location
Abbott Park, IL
Received
Mar 16, 2020
Decided
May 23, 2020
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P120008

Device type

Device class
Class III

Every decision under product code LOK

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Abbott Laboratories, 1915 Hurd Drive, Irving, Texas 75038, USA for the production of the Alinity i System.

Source documents

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.